Cellular ‘atlas’ built to guide precision medicine treatment of rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation that leads to pain, joint damage, and disability, which affects approximately 18 million people worldwide. While RA therapies targeted to specific inflammatory pathways have emerged, only some patients’ symptoms improve with treatment, emphasizing the need for multiple treatment approaches tailored to different disease subtypes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup